Trials bring hope for world–first rheumatoid arthritis treatment

November 14, 2017, University of Queensland
Trials bring hope for world–first rheumatoid arthritis treatment
UQ’s Diamantina Institute Professor Ranjeny Thomas. Credit: University of Queensland

Human trials of an innovative treatment for rheumatoid arthritis developed by The University of Queensland have begun in Brisbane.

DEN-181, a vaccine-style treatment referred to as an 'immunotherapy', targets the underlying cause of the disease rather than treating its inflammatory symptoms.

Patient at a clinical research facility at the Princess Alexandra Hospital began last week. 

UQ's Diamantina Institute research team, led by Professor Ranjeny Thomas, discovered the body's immune system could be 're-educated' to turn off, rather than react to a self-antigen responsible for autoimmune disease like . This led to the development of DEN-181.

DEN-181 is being commercialised by Dendright Pty Ltd, a start-up company of UniQuest, UQ's commercialisation company.

UniQuest CEO Dr Dean Moss said the first-in-human trial was a momentous step towards making the breakthrough research discovery a treatment reality.

"This is an important milestone in developing a new medicine for the millions of people affected by this debilitating disease which destroys joints, causes cardiovascular complications and can reduce life-span," he said.

Professor Thomas, who is also Dendright's Chief Scientific Officer, said the phase 1b clinical trial was the bridge to bringing scientific data into clinical practice.

"The study team will be monitoring and assessing DEN-181 safety and immunological response in patients and we thank the participating patients and referring rheumatologists," she said.

UQ Advancement Director of Development and Philanthropy Andrew Pentland said Arthritis Queensland had been an important supporter of UQ's translational research and approaches to understanding disease biology since the early 1990s.

"Arthritis Queensland has provided philanthropic funding for the Arthritis Queensland Chair of Rheumatology at UQ over many years," he said.

"This is a great example of how a philanthropic partnership can help drive important research outcomes for the benefit of community."

Professor Thomas is the inaugural recipient of the Arthritis Queensland Chair of Rheumatology at UQ.

Dendright entered into a research collaboration and option to license agreement with US-based Janssen Biotech, Inc. (Janssen) in 2013.

This year Janssen agreed to provide additional funding to support further research, including the first-in-human safety trial and tolerability study that began in Brisbane last week.

Explore further: New rheumatoid arthritis treatment moves a step closer to reality

Related Stories

New rheumatoid arthritis treatment moves a step closer to reality

August 15, 2013
A new rheumatoid arthritis treatment has moved a step closer to reality with the announcement of collaboration between a University of Queensland start-up company and a major pharmaceutical firm.

Early clinical trial success for new rheumatoid arthritis treatment

June 3, 2015
University of Queensland researchers have developed a world-first vaccine-style therapeutic approach to treat rheumatoid arthritis, a debilitating disease affecting more than 450,000 people in Australia.

Bioactive lipids and rheumatoid arthritis

November 2, 2017
Sphingolipids – long-chain fatty acid molecules found in cell membranes – are broken down by sphingomyelinase enzymes into bioactive products such as ceramide. Growing evidence suggests roles for sphingolipid metabolites ...

Trial demonstrates benefits of learning sessions for managing rheumatoid arthritis

May 17, 2017
A new study found that group-based quality improvement sessions help rheumatologists care for rheumatoid arthritis patients with the recommended "treat to target" (TTT) approach to care. This approach involves setting a target ...

Studies reveal how shingles vaccine should be used in arthritis patients

August 28, 2017
New research indicates that the live varicella-zoster vaccine—which is given to protect against shingles—elicits robust immune responses in patients when administered several weeks prior to the start of treatment with ...

Rheumatoid arthritis and heart disease: Studies shed light on dangerous connection

October 26, 2013
People with rheumatoid arthritis and other chronic inflammatory conditions are at higher risk of heart disease. Who is in the most danger, why and how best to prevent and detect cardiovascular complications are important ...

Recommended for you

Research shows diet has little influence on precursor to gout

October 11, 2018
Dietary factors have a far smaller influence on urate levels (a precursor to gout) than previously envisaged, new University of Otago research reveals.

More doctor visits lead to less suicide attempts for fibromyalgia patients

September 19, 2018
Fibromyalgia patients who regularly visit their physicians are much less likely to attempt suicide than those who do not, according to a new Vanderbilt University Medical Center study published in Arthritis Care & Research.

Antioxidant found to be effective in treating mice with osteoarthritis

September 14, 2018
A team of researchers in Belgium and the Netherlands has found that feeding a common antioxidant to test mice was effective in treating osteoarthritis. In their paper published in Science Translational Medicine, the group ...

Researchers find answers as to why some people are at risk of gout

September 12, 2018
University of Otago researchers have helped characterise a genetic variant that enables new understanding of why some people are at risk of gout, a painful and debilitating arthritic disease.

Emotions like anger and sadness may cause pain as well as being a result of it

September 10, 2018
While emotions such as anger or sadness are often thought of as being a result of stress or pain, findings recently published by Penn State researchers suggest that negative or mixed emotions could function as stressors themselves.

Dietary carbohydrates could lead to osteoarthritis, new study finds

August 9, 2018
Do your knees ache? According to new findings from the Oklahoma Medical Research Foundation, your diet could be a culprit.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.